387 related articles for article (PubMed ID: 18980214)
1. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
Crook JM; Kobayashi NR
J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
3. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
4. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
5. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
Irion S; Nostro MC; Kattman SJ; Keller GM
Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
[TBL] [Abstract][Full Text] [Related]
6. Human pluripotent stem cells in drug discovery and predictive toxicology.
Laustriat D; Gide J; Peschanski M
Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
[TBL] [Abstract][Full Text] [Related]
7. Regulation of 'stemness' and stem cell differentiation by microRNAs.
Sartipy P; Olsson B; Hyllner J; Synnergren J
IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
Steel D; Hyllner J; Sartipy P
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
[TBL] [Abstract][Full Text] [Related]
9. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?
Cezar GG
Curr Opin Chem Biol; 2007 Aug; 11(4):405-9. PubMed ID: 17662644
[TBL] [Abstract][Full Text] [Related]
10. Novel paths towards neural cellular products for neurological disorders.
Daadi MM
Regen Med; 2011 Nov; 6(6 Suppl):25-30. PubMed ID: 21999259
[TBL] [Abstract][Full Text] [Related]
11. Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
Sartipy P; Bjorquist P; Strehl R; Hyllner J
IDrugs; 2006 Oct; 9(10):702-5. PubMed ID: 17016777
[TBL] [Abstract][Full Text] [Related]
12. The use of induced pluripotent stem cells in drug development.
Inoue H; Yamanaka S
Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
[TBL] [Abstract][Full Text] [Related]
13. Cell therapies: realizing the potential of this new dimension to medical therapeutics.
Singh P; Williams DJ
J Tissue Eng Regen Med; 2008 Aug; 2(6):307-19. PubMed ID: 18618613
[TBL] [Abstract][Full Text] [Related]
14. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
Trosko JE; Chang CC
Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
[TBL] [Abstract][Full Text] [Related]
15. Discovering small molecules to control stem cell fate.
Andrews PD
Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent human stem cells: A novel tool in drug discovery.
Phillips BW; Crook JM
BioDrugs; 2010 Apr; 24(2):99-108. PubMed ID: 20199125
[TBL] [Abstract][Full Text] [Related]
17. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
Romano G
Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
[TBL] [Abstract][Full Text] [Related]
18. The biological restoration of central nervous system architecture and function: part 1-foundations and historical landmarks in contemporary stem cell biology.
Farin A; Liu CY; Elder JB; Langmoen IA; Apuzzo ML
Neurosurgery; 2009 Jan; 64(1):15-39; discussion 34. PubMed ID: 19145154
[TBL] [Abstract][Full Text] [Related]
19. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges.
Nirmalanandhan VS; Sittampalam GS
J Biomol Screen; 2009 Aug; 14(7):755-68. PubMed ID: 19675315
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cells: A journey beyond cell replacement therapies.
Menendez P; Bueno C; Wang L
Cytotherapy; 2006; 8(6):530-41. PubMed ID: 17148029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
